Source: International Congress 2019 – Consequences of sleep-disordered breathing from molecular and clinical points of view
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
A. Canora (Naples, Italy), S. Zanotta (Naples, Italy), G. Polistina (Naples, Italy), C. Nicoletta (Naples, Italy), G. Ghinassi (Naples, Italy), E. Ciasullo (Naples, Italy), D. Galati (Naples, Italy), M. Bocchino (Naples, Italy). Circulating dendritic cell subsets are reduced in obstructive sleep apnoea patients: study correlation with inflammation markers. 895

Member's Comments

No comment yet.

Related content which might interest you: Decreased circulating endothelial progenitor cells in obstructive sleep apnea Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing Year: 2009 Relationship between obstructive sleep apnoea syndrome (OSAS) and the levels of endothelial progenitor cells (EPC) in patients with acute stroke Source: Annual Congress 2011 - Cardiometabolic and neurocognitive changes in obstructive sleep apnoea Year: 2011 LATE-BREAKING ABSTRACT: The pattern of lymphocyte subpopulations including Fas positive cells in patients with obstructive sleep apnea (OSA) Source: Annual Congress 2013 –New physiologic boundaries Year: 2013 Differences in levels of systemic inflammation markers between obese subjects with or without obstructive sleep apnea Source: Annual Congress 2010 - Biomarkers for oxidative stress, inflammation and cardiovascular function in sleep apnoea Year: 2010 Circulating survivin levels in patients with obstructive sleep apnea Source: International Congress 2017 – New pathophysiological insights: intermittent hypoxia, cardiopulmonary function and biomarkers Year: 2017 Monocytes inhibit NK activity via TGF-ß in patients with obstructive sleep apnoea Source: Eur Respir J, 49 (6) 1602456; 10.1183/13993003.02456-2016 Year: 2017 Corticosteroids suppress in vitro tonsillar proliferation in children with obstructive sleep apnoea Source: Eur Respir J 2009; 33: 1077-1084 Year: 2009 Relationship between nerve tissue and inflammatory cell infiltration in the upper airway (UA) of obstructive sleep apnoea (OSA) patients Source: Eur Respir J 2004; 24: Suppl. 48, 445s Year: 2004 Circulating KL-6, a biomarker of lung injury, in obstructive sleep apnoea Source: Eur Respir J 2009; 33: 793-796 Year: 2009 Association between metabolic disturbances and inflammatory markers in obstructive sleep apnea (OSAS) patients Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea Year: 2008 Low circulating levels of invariant natural killer T (iNKT) cells in patients with obstructive sleep apnoea syndrome and impaired functional response to hypoxia: Implications for cancer co-morbidity Source: Annual Congress 2013 –Of mice and men: sleep disordered breathing Year: 2013 The association between hypertension and neutrophil to lymphocyte ratio in patients with obstructive sleep apnea syndrome Source: International Congress 2016 – Effects of hypoxia and sleep apnoea on the lung, heart, and vessels Year: 2016 Relationship between obstructive sleep apnea and human leukocyte antigen variants Source: Virtual Congress 2020 – Consequences for obstructive sleep apnoea and potential modalities for early identification Year: 2020 Circulating cell-derived microparticles in patients with minimally symptomatic obstructive sleep apnoea Source: Eur Respir J 2009; 33: 574-580 Year: 2009 The lymphocyte subset analysis in patients with arterial hypertension and severe obstructive sleep apnea syndrome Source: Annual Congress 2012 - Physiology, obesity and the downstream effects of OSA Year: 2012 Activated CD8 T-lymphocytes in obstructive sleep apnoea Source: Eur Respir J 2005; 25: 820-828 Year: 2005 Frequency of distribution of IL-1, IL-6 and TNFa gene polymorphism in patients with obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2006 - Metabolic control in obstructive sleep apnoea Year: 2006 Circulating ICAM-1 and VCAM-1 levels in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2006; 28: Suppl. 50, 414s Year: 2006 Production of TNF-α, MMPs, and MCP-1 by monocytes and hypoxic stress in patients with obstructive sleep apnea syndrome (OSAS) Source: Eur Respir J 2004; 24: Suppl. 48, 331s Year: 2004 The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 113s Year: 2004